retatrutide first week Phase III study demonstrates 30% weight loss Lilly Prepares for Retatrutide FDA

The physiology of glucagon-like peptide 1

Nocturnal glucose metabolism after bedtime injection of insulin glargine or neutral protamine hagedorn insulin in patients with type 2 diabetes

Who might want to look elsewhere

I Am Taking a GLP-1 Weight-Loss MedicationWhat Should I Know? JAMA Internal Medicine , vol

Its manufacturing and storage are more streamlined, and its oral administration is more convenient, as it eliminates the need for a 30-minute fasting window

[232][233][234][235] GLP-1 exerts its effect on postprandial glucose concentrations through several mechanisms, including enhancing insulin secretion and suppressing postprandial glucagon secretion in a glucose-dependent manner